News Blog

We are looking for a highly motivated team member to join our young and open-minded research group. If you are enthusiastic about supporting the translation of preclinical findings into personalized medicine, we look forward to receiving your detailed application.

We are happy to get the opportunity to present our work at the MSNZ Symposium. Lydia will give a talk about therapeutic targeting of small-cell lung cancer metastasis.

The IPMM (Interdisciplinary Program Molecular Medicine) days will take place luckily in person and Tabea will present her poster with the title Deciphering the Molecular Mechanisms of LIN28B in Tumor Induction, Tumor Maintenance and Metastatic tracks in squamous cell lung cancer.

Today Tabea has her first day in the lab. She will investigate novel therapeutic strategies for squamous cell lung carcinomas (SQLC). LIN28B expression marks a clinically relevant subgroup of patients which may benefit from anti-angiogenic therapy and immune checkpoint blockade. Welcome Tabea!

After a long break due to the COVID-19 pandemic, the annual congress of the DGHO (Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie) will take place in Berlin. Lydia is excited to talk about metastatic track and present our team's data on metastasis of small cell lung cancer in the session Metastasis as an invited speaker.